Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions

Journal of the American Academy of Dermatology

Volumn 69, Issue 4, 2013, Pages 657-658

  Chiang, Herbert C ^a   Anadkat, Milan J ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ISOTRETINOIN; TETRACYCLINE DERIVATIVE;

ACNE; ACNEIFORM PAPULOPUSTULAR ERUPTION; DRUG ERUPTION; DRUG TOLERABILITY; HUMAN; LETTER; LONG TERM CARE; PAPULE; PRIORITY JOURNAL; RASH;

EID: 84884294797     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.05.032     Document Type: Article

References (4)

1. R.S. Herbst Review of epidermal growth factor receptor biology Int J Radiat Oncol Biol Phys 59 2004 21 26
2. R. Gutzmer, J.C. Becker, A. Enk, C. Garbe, A. Hauschild, and M. Leverkus Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician J Dtsch Dermatol Ges 9 2011 195 203
3. R. Perez-Soler, and L. Saltz Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? J Clin Oncol 23 2005 5235 5246
4. J.B. Bachet, L. Peuvrel, C. Bachmeyer, Z. Reguiai, P.A. Gourraud, and O. Bouche Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review Oncologist 17 2012 555 568